Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • News

    Dapagliflozin meets primary endpoint in the DAPA-HF trial

    August 21, 2019

    AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.

  • News

    New biomarker model outmatches conventional risk factors for predicting mortality

    August 20, 2019

    Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect when combined into one model.

  • 1
    News

    FDA approves Xenleta for community-acquired bacterial pneumonia treatment

    August 20, 2019

    The approval was based on results from two trials with a total of 1,289 patients.

  • 1
    News

    Short-term parenteral antibiotics effective for bacteremic UTI in young infants

    August 20, 2019

    No significant differences in urinary tract infection recurrence or hospital reutilization between short- and long-term parenteral antibiotic groups.

  • News

    Post-TAVR anticoagulation alone fails to cut stroke risk in AFib

    August 19, 2019

    By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.

  • 1
    News

    Differential monocytic HLA-DR expression prognostically useful in PICU

    August 19, 2019

    LJUBLJANA, SLOVENIA – European pediatric “study of the year” paves way for novel sepsis immunotherapies.

  • 1
    News

    Presepsin can rule out invasive bacterial infection in infants

    August 16, 2019

    LJUBLJANA, SLOVENIA – Novel test addresses unmet need for biomarker for invasive bacterial infection.

  • News

    ‘Substantial burden’ of enterovirus meningitis in young infants

    August 16, 2019

    LJUBLJANA, SLOVENIA – “Not a single one of the patients with enterovirus/human parechovirus meningitis had a secondary bacterial infection – and that has important implications for management of our antibiotic stewardship programs,” said Dr. Seilesh Kadambari.

  • 1
    News

    CDC updates recommendation for serologic Lyme disease detection

    August 15, 2019

    The CDC’s updated recommendation is based on the approval of a new test that uses a modified two-test methodology different from the two-test methodology first recommended in 1994.

  • 1
    News

    How to nearly eliminate CLABSIs in children’s hospitals

    August 15, 2019

    One hospital went 6 months without a central line–associated bloodstream infection after quality improvements.

Previous1 … 194 195 196 197 198 … 401Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences